on BioVersys AG
BioVersys to Present at H.C. Wainwright Conference
BioVersys AG, a clinical stage biopharmaceutical company, will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York. The event will occur from September 14-16, 2026. BioVersys focuses on developing novel antibacterial products targeting multi-drug resistant bacteria.
Hernan Levett, CFO of BioVersys, will deliver a corporate overview on September 16, 2026. The presentation will take place at the Lotte New York Palace. Additionally, a session by CEO Dr. Marc Gitzinger will be available on demand, live-streamed on September 11, 2026, with replay access for 90 days. Attendees can arrange one-on-one meetings with BioVersys representatives during the conference.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BioVersys AG news